Inovio Pharmaceuticals Inc. (INO)

Inovio Pharmaceuticals Inc. (INO $1.65)
- $1.65 Cap: $114M
- View INO Profile
- View Questions on INO

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Inovio Pharmaceuticals Inc. (INO $1.65)
- $1.65 Cap: $114M
- View INO Profile
- View Questions on INO

Q: Despite all the short squeezing news on this stock. What do you guys think of INO as a biotech company, balance sheet, insider ownership, pipeline, upcoming earnings, long term outlook, risks, covid pipeline......

Thanks

Read Answer Asked by James on February 02, 2021

Regeneron Pharmaceuticals Inc. (REGN $737.45)
- $737.45 P/E (TTM): 18.3X Cap: $78.66B
- View REGN Profile
- View Questions on REGN
Pfizer Inc. (PFE $27.41)
- $27.41 P/E (TTM): 20.18X Cap: $155.40B
- View PFE Profile
- View Questions on PFE
IMV Inc. (IMV $1.12)
- View IMV Profile
- View Questions on IMV
Inovio Pharmaceuticals Inc. (INO $1.65)
- $1.65 Cap: $114M
- View INO Profile
- View Questions on INO
Novavax Inc. (NVAX $9.74)
- $9.74 P/E (TTM): 4.12X Cap: $1.66B
- View NVAX Profile
- View Questions on NVAX
Moderna Inc. (MRNA $52.37)
- $52.37 Cap: $20.78B
- View MRNA Profile
- View Questions on MRNA
BioNTech SE (BNTX $89.31)
- $89.31 Cap: $22.61B
- View BNTX Profile
- View Questions on BNTX

Q: Is there a Canadian company that you would recommend that possibly would benefit from a vaccine to overcome Covid 19, if not what U.S. or international company would you recommend? Thank You.

Read Answer Asked by Brian on July 14, 2020

Amgen Inc. (AMGN $349.92)
- $349.92 P/E (TTM): 25.38X Cap: $189.47B
- View AMGN Profile
- View Questions on AMGN
Johnson & Johnson (JNJ $237.60)
- $237.60 P/E (TTM): 21.59X Cap: $571.51B
- View JNJ Profile
- View Questions on JNJ
Inovio Pharmaceuticals Inc. (INO $1.65)
- $1.65 Cap: $114M
- View INO Profile
- View Questions on INO
Novavax Inc. (NVAX $9.74)
- $9.74 P/E (TTM): 4.12X Cap: $1.66B
- View NVAX Profile
- View Questions on NVAX
Repligen Corporation (RGEN $117.61)
- $117.61 P/E (TTM): 138.69X Cap: $6.62B
- View RGEN Profile
- View Questions on RGEN
Moderna Inc. (MRNA $52.37)
- $52.37 Cap: $20.78B
- View MRNA Profile
- View Questions on MRNA
Adaptive Biotechnologies Corporation (ADPT $13.50)
- $13.50 Cap: $2.04B
- View ADPT Profile
- View Questions on ADPT
Sorrento Therapeutics Inc. (SRNE)
- P/E (TTM): -0.1X Cap: $141M
- View SRNE Profile
- View Questions on SRNE

Q: Hello 5i Team,
Could you please tell me the names of the companies that are developing a vaccine against Covid 19. Is there an ETF that tracks them?
Thanks,
Antoine

Read Answer Asked by Antoine on June 30, 2020